Search alternatives:
significant burdens » significant burden (Expand Search), significant barriers (Expand Search), significant binding (Expand Search)
greater disease » greater decrease (Expand Search), related disease (Expand Search), greater sense (Expand Search)
sizes decrease » scores decreased (Expand Search), rivers decreased (Expand Search)
Showing 1 - 20 results of 6,446 for search '(( significant ((greater disease) OR (sizes decrease)) ) OR ( significant burdens decrease ))', query time: 0.43s Refine Results
  1. 1
    Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China.

    Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Effect Size Analysis of Influenza Testing and Specimen Detection before and after the COVID-19 Pandemic.

    Effect Size Analysis of Influenza Testing and Specimen Detection before and after the COVID-19 Pandemic. by Nadia Nisar (311028)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China.

    Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    <i>Ctsz</i><sup><i>−/−</i></sup> mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.

    <i>Ctsz</i><sup><i>−/−</i></sup> mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Cases and age-standardized rates of hematological malignancies in mainland China and their temporal trends.

    Cases and age-standardized rates of hematological malignancies in mainland China and their temporal trends. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Projections of incidence for hematological malignancies in mainland China.

    Projections of incidence for hematological malignancies in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China.

    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Cases and age-standardized rates of hematological malignancies in Taiwan and their temporal trends.

    Cases and age-standardized rates of hematological malignancies in Taiwan and their temporal trends. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    The raw data used in this study.

    The raw data used in this study. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China.

    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Projections of mortality for hematological malignancies in mainland China.

    Projections of mortality for hematological malignancies in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Scaling of overall health burden with yearly expenditure growth.

    Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells.

    Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

    Published 2024
    Save to List
    Saved in:
  14. 14
    Evolution of health burden and life expectancy under different expenditure scenarios.

    Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes.

    Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Significantly Enriched Pathways.

    Significantly Enriched Pathways. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Comparison of postoperative outcomes and financial burden between migrated and non-migrated primary knee arthroplasty patients.

    Comparison of postoperative outcomes and financial burden between migrated and non-migrated primary knee arthroplasty patients. by Fanqiang Meng (4786071)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Soil partice-size distribution.

    Soil partice-size distribution. by Yonggang Huang (223155)

    Published 2025
    Save to List
    Saved in:
  19. 19
    Slightly greater significance of m7G over m6A in epilepsy via multiple machine learning algorithms.

    Slightly greater significance of m7G over m6A in epilepsy via multiple machine learning algorithms. by Jiangli Zhao (2308330)

    Published 2025
    Save to List
    Saved in:
  20. 20
    Significant condition.

    Significant condition. by Junxia Zhou (14381598)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: